Syngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Regulatory & Legal View source PDF Explain this filing

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹726.00

prior close

₹727.80

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.8%+1.0% vs market

Healthcare Services peers, median of 50sector · industry level+0.9%+0.9% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Smallcap 250 and 0.9 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.3

15m

+0.2

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+0.8+1.0+0.9+0.9

Next day

+3.8+1.1+2.8-0.3+4.1

-10.2+1.0-11.2-0.4-9.8

-13.3-1.4-11.8-2.0-11.3

-15.2-0.9-14.3-1.5-13.8

-13.6-0.7-12.8-1.9-11.6

-13.6-2.5-11.1-3.7-9.9

15d

-11.8+1.8-13.7-2.8-9.0

-12.7+4.3-17.1-2.5-10.2

-12.6+8.2-20.8-1.9-10.7

-6.9+13.2-20.1+3.7-10.6

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Services peers, median of 50Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syngene International has informed the stock exchange about the pendency of litigation or dispute that may impact the company, as required under SEBI listing rules. The company has disclosed this as part of its periodic compliance obligations. No further details about the specific nature, quantum, or outcome of the litigation have been shared in this filing. Shareholders will need to await additional disclosures or the company's annual report for full context on the matter.

Likely market impact

At this stage, the disclosure is procedural and does not indicate a specific adverse outcome. Investors should monitor for further updates to understand the financial or operational impact, if any.